INFILTRATING DUCT CARCINOMA
\ˈɪnfɪltɹˌe͡ɪtɪŋ dˈʌkt kˌɑːsɪnˈə͡ʊmə], \ˈɪnfɪltɹˌeɪtɪŋ dˈʌkt kˌɑːsɪnˈəʊmə], \ˈɪ_n_f_ɪ_l_t_ɹ_ˌeɪ_t_ɪ_ŋ d_ˈʌ_k_t k_ˌɑː_s_ɪ_n_ˈəʊ_m_ə]\
Sort: Oldest first
-
An invasive (infiltrating) carcinoma of the breast. This carcinoma in which no special histological feature is recognized is designated NOS or Not Otherwise Specified and is by far the most common ductal tumor, accounting for almost 70% of breast cancers. It is characterized by stony hardness upon palpation. It commonly metastasizes to the axillary lymph nodes and its prognosis is the poorest of the various ductal types. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1205)
By DataStellar Co., Ltd
Word of the day
Proto Oncogene Proteins c erbB 2
- cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.